Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Cerevel Therapeutics LLC
Sponsor

Cerevel Therapeutics LLC

United States 222 Jacobs Street Suite 200, 02141-2297, United States

About the sponsor

Clinical activity in schizophrenia focuses on adult participants and the long-term use of emraclidine and related investigational therapy programs.

  • Psychiatric disorders
  • Antipsychotic treatment development
  • Long-term tolerability

The research interest centers on sustained treatment of psychotic disorders in adult populations.

About Specializations

Cerevel Therapeutics LLC runs clinical trials in conditions such as Parkinson's disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Parkinson's disease

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tavapadon
  • Sponsor:Cerevel Therapeutics LLC

Long-term Safety Study of Emraclidine for Adults with Schizophrenia

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Emraclidine
  • Sponsor:Cerevel Therapeutics LLC

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.